2012. EULAR Annual European Congress – Tofacitinib versus biologic treatments with and without methotrexate in patients with active rheumatoid arthritis who have had an inadequate response to traditional disease modifying anti-rheumatic drugs. A network meta-analysis

Vieira MC, Wallenstein GV, Bradley JD, Gruben D, Koncz T, Swillich SH, Jansen JP. Tofacitinib versus biologic treatments with and without methotrexate in patients with active rheumatoid arthritis who have had an inadequate response to traditional disease modifying anti-rheumatic drugs. A network meta-analysis. Presented at: EULAR Annual European Congress of Rheumatology; June 10, 2012; Barcelona, Spain.